Optimization of M3 Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPDJOURNAL OF MEDICINAL CHEMISTRYIF6.82023-08-102PRE
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic DisordersJOURNAL OF MEDICINAL CHEMISTRYIF6.82023-04-052PRE
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-07-286PRE
Design, Synthesis, and Biological Characterization of Inhaled p38?/? MAPK Inhibitors for the Treatment of Lung Inflammatory DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-05-115PRE
Discovery of M3 Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary DiseaseJOURNAL OF MEDICINAL CHEMISTRYIF6.82021-06-1810PREAI
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-12-1418PREAI
Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administrationEUROPEAN RESPIRATORY JOURNALIF212017-12-063PRE
In vitro pharmacological characterization of the novel inhaled bronchodilator CHF6366 acting as dual muscarinic antagonist/β2-agonist (MABA)EUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobinEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72015-04-017PREAI
CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary AdministrationJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82015-03-0164OAAI
Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory DiseasesJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-01-2949PREAI
Bronchodilator Activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a Potent, Long-Acting, and Selective Muscarinic M3 Receptor AntagonistJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82010-12-0123PREAI
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: Synthesis and evaluation of their phosphodiesterase 4 inhibitory activityBIOORGANIC & MEDICINAL CHEMISTRYIF32010-05-0123PRE
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (part 2)JOURNAL OF MEDICINAL CHEMISTRYIF6.82007-03-1313OAAI
Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1)JOURNAL OF MEDICINAL CHEMISTRYIF6.82007-03-1325OAAI
Structural determinants of Torpedo californica acetylcholinesterase inhibition by the novel and orally active carbamate based anti-Alzheimer drug ganstigmine (CHF-2819)JOURNAL OF MEDICINAL CHEMISTRYIF6.82006-08-0152PREAI
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivativesBIOORGANIC & MEDICINAL CHEMISTRYIF32006-05-0118PRE
Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity (vol 12, pg 3763, 2004)BIOORGANIC & MEDICINAL CHEMISTRYIF32004-09-010OAAI
Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activityBIOORGANIC & MEDICINAL CHEMISTRYIF32004-07-0131PREAI
Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissueJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82002-03-017PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向